Salinomycin combined with oncostatin M, a cytokine of the interleukin-6 family, reduced the CD133+ fractions of HepG2 cells, decreased cell invasion and stem cell-related gene expression, and triggered apoptosis in HCC HepG2 cells. Here, PROM1 is linked to hepatocellular carcinoma.